Jones Financial Companies Lllp Atossa Therapeutics, Inc. Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
A detailed history of Jones Financial Companies Lllp transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 380 shares of ATOS stock, worth $376. This represents 0.0% of its overall portfolio holdings.
Number of Shares
380Holding current value
$376% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATOS
# of Institutions
88Shares Held
27.7MCall Options Held
63.6KPut Options Held
53.2K-
Black Rock Inc. New York, NY9.2MShares$9.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.59MShares$6.52 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.85MShares$2.82 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.86MShares$1.84 Million0.0% of portfolio
-
State Street Corp Boston, MA1.73MShares$1.71 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $125M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...